NCT05194176

Brief Summary

Blunt chest trauma comprises over 10% of all trauma patients presenting to emergency departments worldwide and is the most frequent injury in polytrauma patients. It is associated with high risk (\>10%) of pulmonary complications such as pneumonia. Pillars of treatment are adequate pain relief, respiratory function exercises and rapid mobilisation through physiotherapy. Inadequate pain control can result in restricted ventilatory function and in reduced mobility, both resulting in a higher risk of particularly pulmonary complications. Virtual Reality (VR) might be an easy to use, individualized, and harmless technique that can facilitate pulmonary recovery and aid in the prevention of complications through reducing pain and promoting exercising. The investigators hypothesize that VR improves respiratory function and mobilisation in the post-acute phase of blunt chest trauma by distracting patients from pain and stress, and by stimulating pulmonary and physical exercise.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 18, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 28, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 23, 2023

Completed
Last Updated

March 8, 2023

Status Verified

March 1, 2023

Enrollment Period

11 months

First QC Date

January 2, 2022

Last Update Submit

March 6, 2023

Conditions

Keywords

Virtual RealityTraumaPulmonary Recovery

Outcome Measures

Primary Outcomes (2)

  • Inspiration volume, mean change from baseline

    Mean change from baseline in inspiration volume in ml, measured with an incentive spirometer (Voldyne)

    From baseline to end of treatment at day 5.

  • Inspiration volume, repeated measures over 5 days

    change in mean daily inspiration volume in mL, measured with an incentive spirometer (Voldyne)

    Twice daily from enrollment to day 5 of treatment

Secondary Outcomes (8)

  • Time spent sitting or standing, mean change from baseline

    Continuously from enrollment to end of treatment at day 5.

  • Length of hospital stay

    At end of follow-up, 30 days after discharge

  • Pulmonary complications during admission

    At end of follow-up, 30 days after discharge

  • Transfers to ICU

    At end of follow-up, 30 days after discharge

  • Readmission within 30 days

    At end of follow-up, 30 days after discharge

  • +3 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

The control group will receive usual care. Patients will be instructed to perform respiratory exercises 8 times daily for 10 minutes and to extend these exercises 2 times daily with (sitting) physical exercises for an additional 10 minutes. Respiratory exercises include using incentive spirometry and exercises for deep breathing, huffing and coughing. Patients receive a leaflet with the exercises described and the exercises will be performed once daily under supervision of a physiotherapist. The other sessions will be unsupervised.

Virtual Reality

EXPERIMENTAL

The intervention group will be instructed to perform the respiratory exercises using the VR-intervention 8 times daily for 10 minutes and to extend these exercises 2 times daily with (sitting) physical exercises for an additional 10 minutes. The respiratory exercises in VR are comparable to the exercises in usual care but performed in a virtual environment and without incentive spirometry. The physical exercises consist of several games through which patients are challenged to reach out to objects while engaging their core. Patients are allowed to continue these exercises or play some relaxation games for up to 30 minutes per session in total. The exercises will be performed once daily under supervision of a physiotherapist. The other sessions will be unsupervised.

Device: Virtual Reality

Interventions

For all VR exercises a head mounted display (HMD), the PICO G2 4K (Barcelona, Spain) will be used. Together with SyncVRMedical (Utrecht, Netherlands) a VR dashboard has been created from which patients can chose the different exercises.

Virtual Reality

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted to the trauma ward with sustained blunt chest trauma
  • Age≥16
  • Patient is willing and able to comply with the study protocol

You may not qualify if:

  • Neurotrauma with GCS ≤13
  • History of dementia, seizures, epilepsy
  • Severe hearing/visual impairment not corrected
  • Head wounds or damaged skin with which comfortable and hygienic use is not possible.
  • Stay at intensive care unit (ICU) during current hospital admission.
  • Erect position in bed not possible/allowed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud university medical center

Nijmegen, Gelderland, 6525 GA, Netherlands

Location

Related Publications (1)

  • Groenveld TD, Smits IG, Scholten N, de Vries M, van Goor H, Stirler VM. Pulmonary and Physical Virtual Reality Exercises for Patients With Blunt Chest Trauma: Randomized Clinical Trial. JMIR Serious Games. 2024 Dec 9;12:e54389. doi: 10.2196/54389.

MeSH Terms

Conditions

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2022

First Posted

January 18, 2022

Study Start

March 28, 2022

Primary Completion

February 23, 2023

Study Completion

February 23, 2023

Last Updated

March 8, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Non-identifiable patient characteristics, questionnaire data, diaries and measurements will be shared in a pseudonimised manner in DANS EASY under restricted access

Shared Documents
SAP, ANALYTIC CODE

Locations